An official website of the United States government
Here’s how you know
Official websites use .gov
A .gov website belongs to an official government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.
The current pandemic is due to the spread of SARS-CoV-2, a novel coronavirus that causes a severe respiratory infection known as COVID-19. Recent reports have noted the presence of viral RNA in stool samples, offering unique measurement challenges and opportunities in three areas:
Biosurveillance of Wastewater: Local public health labs can monitor sewage treatment facilities to measure the rise and fall of COVID-19 in a community; potentially as a tool to help predict future waves of outbreaks.
Feces as a New Target for Diagnostic Testing: Currently there are >140 commercially available COVID-19 diagnostic tests. While initially validated using nasal swabs, these same tests can potentially be re-validated in fecal material.
Fecal Microbiome Transplantation (FMT) Safety: Every year, thousands of patients receive FMTs to treat infections and other health conditions. The FDA has released a safety alert stating donor material must be screened for COVID-19, as feasible.
Workshop Purpose and Expected Outcomes
To address these new challenges and opportunities, we are organizing a virtual workshop that convenes stakeholders in the above areas. Workshop goals are to:
Gain insight on measurement challenges associated with detecting SARS-CoV-2 in fecal material.
Disseminate NIST’s unique expertise in producing standards and reference materials to address urgent measurement challenges.
Determine how the NIST Human Whole Stool Reference Material (RGM 10162), currently under development, could potentially be modified and deployed to address these emerging needs.
A workshop report will summarize the discussion and inform planning for ongoing and future NIST efforts.
1:05 pm Bharat Ramakrishna, OpenBiome, “Fecal microbiota transplantation: Responding to the COVID-19 pandemic”
1:20 pm Manoj Dadlani, CosmosID, “Overcoming the Validation Challenges of a Diagnostic for SARS-CoV-2 in Stool”
1:35 pm Katerina Papp, Water Quality R&D, Southern Nevada Water Authority, “Wastewater Surveillance of SARS-CoV-2 in Southern Nevada: Challenges for Sample Collection, Processing, and Analysis”
1:50 pm Kyle Bibby, University of Notre Dame, Title TBA
2:05 pm Aparna Keshaviah, Mathematica, “Testing Wastewater for SARS-CoV-2: Aligning Validation and Policy Needs”
2:20 pm Panelist Q&A
2:55 pm Scott Jackson, NIST, Wrap-Up
3:00 pm Conclude Webinar
CONTACT
Scott Jackson fecalstandards [at] nist.gov (fecalstandards[at]nist[dot]gov) 240-620-7321